Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis - Wikidata - awgldk - TriplyDB

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis

http://www.wikidata.org/entity/Q27027981

about

Mucin-Type O-Glycosylation in Gastric Carcinogenesis Novel targets in the treatment of advanced gastric cancer: a perspective review Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis.Molecular classifications of gastric cancers: Novel insights and possible future applications.Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients.Prognostic significance of interleukin 17 in cancer: a meta-analysis.Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma.YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway Targeted therapies in gastric cancer and future perspectives.Clinicopathological Significance and Diagnostic Accuracy of c-MET Expression by Immunohistochemistry in Gastric Cancer: A Meta-Analysis.PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications.Ramucirumab: targeting angiogenesis in the treatment of gastric cancer.Targeting the MET pathway for potential treatment of NSCLC.Role of c-mesenchymal-epithelial transition pathway in gastric cancer.Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer.Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates.Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer.Detection of MET amplification in gastroesophageal tumor specimens using IQFISH.Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays.Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study.c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer.What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives

P2860

Q26740541-EF8EE3EE-B6DD-4B55-91BE-1C54A47A4D81 Q26765208-385AD7CB-4289-4517-BB14-1C742FD11392 Q26785700-0D4FF8BE-D0CF-4DEB-99B9-B5FBF066A2C8 Q31112933-320D9110-10B6-4D45-9AC1-749B48505C5F Q33618725-03A403A2-C2E1-4746-9A35-5D6E110B19B4 Q33696201-A1514D32-C07F-4D1F-97BB-04346C82A28F Q34446136-C66D9BCC-38B7-4942-9D1B-C97BC9DB05B9 Q34547722-A204F819-317A-4615-ABCB-6C644691BBDA Q35017808-07ACA821-9855-4EA9-99EC-2B851E0B759A Q35433475-BB449A60-645F-496C-BF9A-1749F6426326 Q35694945-5D9A1DEF-B7CA-4AC4-89C7-9C9BF6713F19 Q36471685-99BC4785-0E85-4855-9CA5-50A78357E826 Q37342442-FE0239BC-3742-4635-81FB-2CD15B202B87 Q37376230-F1E451DB-DFCC-4164-9058-63A3607D2E46 Q37705824-892B34B7-3EA3-42D6-AD09-82AB4CD10C3D Q38263575-B121F68B-6EF9-407B-A3D1-705785A71EC3 Q38286373-6434A080-DC82-4544-AE83-0D651B3BCAFB Q38297235-AED09C77-CABF-488C-B21D-77B9C1B2595A Q38424220-057CAC36-C192-4314-B601-FDEB943D449C Q38856729-BBDAB044-96A3-44C1-972D-E86AAE38B589 Q41116584-01C25631-2CBB-477B-B2A3-6AD636B8EE9B Q42499937-03D08687-8193-4E23-A47D-DD9079B51680 Q46668930-CD557F02-F1D9-4962-9D84-BC776D02421E Q47171647-605FCAA6-3572-40B4-AD3B-00C55BEBBC3F Q47564950-B796DCA4-8396-49D5-8A3F-B7D0E67E9036 Q47911980-FA15D4EE-8047-458C-A741-4DEB81ABA4AA Q49324556-040D527B-27D2-4601-A2F7-5FAC4591A6B0 Q55656669-28F24D6F-2589-450B-A8E6-37C56DF00E9E Q57159608-EA28A0FA-EA1F-4969-936E-34BD134A21E6

P2860

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis

http://www.wikidata.org/entity/Q27027981

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Prognostic significance of MET ...... atic review with meta-analysis

@ast

Prognostic significance of MET ...... atic review with meta-analysis

@en

Prognostic significance of MET ...... atic review with meta-analysis

@nl

type

label

Prognostic significance of MET ...... atic review with meta-analysis

@ast

Prognostic significance of MET ...... atic review with meta-analysis

@en

Prognostic significance of MET ...... atic review with meta-analysis

@nl

prefLabel

Prognostic significance of MET ...... atic review with meta-analysis

@ast

Prognostic significance of MET ...... atic review with meta-analysis

@en

Prognostic significance of MET ...... atic review with meta-analysis

@nl

P1433

Q27027981-0D28A239-3AD2-4ED7-AEE5-74954E2059DC

P1476

Q27027981-162C10F2-889B-43D0-9A18-79B918C3F94A

P2093

Q27027981-36884615-4432-496D-B72E-1D76D3844844

Q27027981-49EBECAE-2E56-4AA5-87FD-D21B226D49E5

Q27027981-58EDFABC-A481-4CB7-91B0-6A75BFF1ECC1

Q27027981-908805D8-43F3-4740-ACC3-4192D7C9E40B

Q27027981-AB1A4C40-D194-4D22-BFEA-B6C350496DEA

Q27027981-C61CEAC2-320D-4E1E-AFE3-A6CFD2052AF2

Q27027981-CE953007-B1C4-471C-8A5F-9A9CFC6BF29C

Q27027981-DE7280E5-B539-4164-B7A5-A7F06077780B

P275

Q27027981-22B196A2-2DD1-484F-8CEF-F1728E0E5ABB

P2860

Q27027981-0923D756-39CB-4887-9AEF-49E39DCA7CEC

Q27027981-09D1F114-C995-46B5-A2F5-835A6ABBCA35

Q27027981-1400384D-0735-4792-BE2A-0C4150E175A5

Q27027981-15C8D99E-2740-40DA-9A87-CDCF09FB6D6E

Q27027981-15E873B5-87A6-49BE-8CF4-8C4385C983B9

Q27027981-19615281-DD5C-4E23-BB69-F3A0D755C4BD

Q27027981-1DDBF8A9-3649-4DFF-B11E-AE5BD53723AE

Q27027981-263CD9E2-CEA0-46B3-87BA-F6668B587CAB

Q27027981-2D3BD611-E2E6-421A-A527-B1BD356A66AB

Q27027981-318FACB6-C1C8-4AC1-85FD-19946C8C25A4

P304

Q27027981-02DB42E6-DBE3-4B0A-A57B-91392DBEBF25

P31

Q27027981-1A0AC437-047F-48DD-9011-1DC0B11290D8

Q27027981-50D95BEC-3283-4DD1-800E-657E8E5EFB8B

Q27027981-58E63B8A-DFD1-4B2D-A7B4-7A8B965F4C16

Q27027981-5CE7A2F4-3874-465C-8A38-3295FED64530

P3181

Q27027981-8EC97F63-FF27-4D9E-BDC0-4F00032A08C9

P356

Q27027981-EDE29609-C6D5-4B8C-AF71-53EC3DBE7FB3

P407

Q27027981-002DB5F4-0DA5-4FE4-BE48-706A7C649A99

P433

Q27027981-A3A2D7CF-C83A-4316-B80D-1D0BA25E1FF5

P478

Q27027981-12FAE48A-3EA7-4DE9-8FFD-3A8150A2C7EC

P5008

Q27027981-38A62109-A06C-44FD-B979-FF009060B46B

P577

Q27027981-06F3B5AE-6111-4406-A5EF-966E59499019

Q27027981-DF8FC745-BE6C-4405-87BD-C2AA687F361B

P5875

Q27027981-75A7B44B-FCFA-419F-BEF3-9517A2E2CF9A

P698

Q27027981-5B0200B9-F6D8-4C7E-8F97-DC2E63B19913

P921

Q27027981-0845181A-8B53-422F-A3A6-D39F6E02A68F

Q27027981-09B84A4E-29D5-4914-A9C6-E0139A6D4954

Q27027981-166EE658-C598-4C96-96BD-68E91DADF64C

Q27027981-3DDB02C8-F00F-484C-9AB5-CE4727676E2D

Q27027981-3F06FBFF-38CA-496A-AE02-DC52A1A4C198

Q27027981-85B61C46-C32A-4E95-BFE2-63CFD1AF7C3D

Q27027981-9551F3E8-B63A-484D-A971-F5D374E57C45

Q27027981-EB78EF80-5E1F-4710-AAE8-B9DB9FA064E1

Q27027981-F1BBBF08-8EBF-443C-9A31-DF7502788362

Q27027981-F9659820-1A97-47B1-9B76-B7F9C2C365CA

P932

Q27027981-95F3A741-EEAD-4EFB-A529-6382D8F8B135

P3181

P356

JOURNAL.PONE.0084502

P1433

P1476

Prognostic significance of MET ...... atic review with meta-analysis

@en

P2093

Jing Gao

http://www.w3.org/2001/XMLSchema#string

Lin Shen

http://www.w3.org/2001/XMLSchema#string

Qianqian Wang

http://www.w3.org/2001/XMLSchema#string

Sai Ge

http://www.w3.org/2001/XMLSchema#string

Yan Zhu

http://www.w3.org/2001/XMLSchema#string

Yanyan Li

http://www.w3.org/2001/XMLSchema#string

Yilin Li

http://www.w3.org/2001/XMLSchema#string

Zhi Peng

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Global cancer statistics

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis.

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.

P304

e84502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

3237599

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0084502

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259701507

http://www.w3.org/2001/XMLSchema#string

P698

24416238

http://www.w3.org/2001/XMLSchema#string

P921

stomach neoplasm

cell surface receptor

genetic variation

regulation of gene expression

membrane proteins

proto-oncogene proteins

neoplasm proteins

P932

3885582

http://www.w3.org/2001/XMLSchema#string